LCM
Laurion Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-52,828
| Closed | -$1.07M | – | 359 |
|
|
2023
Q4 | $1.07M | Buy |
+52,828
| New | +$1.07M | 0.01% | 138 |
|
|
2023
Q2 | – | Sell |
-21,401
| Closed | -$368K | – | 390 |
|
|
2023
Q1 | $368K | Hold |
21,401
| – | – | ﹤0.01% | 180 |
|
|
2022
Q4 | $475K | Sell |
21,401
-223,722
| -91% | -$4.97M | ﹤0.01% | 156 |
|
|
2022
Q3 | $1.97M | Hold |
245,123
| – | – | 0.01% | 131 |
|
|
2022
Q2 | $1.71M | Hold |
245,123
| – | – | 0.03% | 125 |
|
|
2022
Q1 | $3.71M | Hold |
245,123
| – | – | 0.05% | 82 |
|
|
2021
Q4 | $5.38M | Sell |
245,123
-30,000
| -11% | -$658K | 0.05% | 81 |
|
|
2021
Q3 | $7.42M | Hold |
275,123
| – | – | 0.03% | 118 |
|
|
2021
Q2 | $6.63M | Sell |
275,123
-1,171
| -0.4% | -$28.2K | 0.04% | 91 |
|
|
2021
Q1 | $12M | Buy |
276,294
+218,294
| +376% | +$9.47M | 0.06% | 109 |
|
|
2020
Q4 | $2.4M | Buy |
+58,000
| New | +$2.4M | 0.02% | 146 |
|